Skip to content
Home arrow Literature arrow Newsletters - French arrow Metabolic Acidosis: A Common Factor?
Metabolic Acidosis: A Common Factor? PDF Print E-mail

Is Metabolic Acidosis a Common Factor in Many Degenerative Diseases?

George M. Tamari, Ph.D.*
Original published in: Journal of Orthomolecular Medicine 1987;2:106-110


The possible role of the Electron Transport System in energy production at cell level is discussed along with an indication of the adaptabily of LDH to different metabolic needs. There is a working hypothesis suggesting the connection between metabolic acidosis, lowered energy production and the appearance of different degenerative diseases. Tissue minerals may serve as a screening tool for the assessment of nutritionally, socially or environmentally induced metabolic acidosis.


The investigation into cell respiration by Otto Warburg goes back 75 years. Until that time cancer cells were distinguished from normal cells by morphological differences only. A crucial discovery was made by Warburg and his co-workers; they established the first functional qualitative difference between normal and cancerous cells - a bio-chemical change. which is significant in cellular energy production.

Let us examine this process more closely. A normally functioning mitochondrion produces energy in two phases: a) by breaking down one mole of six carbon glucose into two moles of three carbon pyruvate, and b) then entering the Krebs cycle to produce the final breakdown products, carbon dioxide and water

The energy produced is stored in energy rich phosphate bonds through oxidative phosphorylation of adenosine diphosphate into adenosine triphosphate (ADP to ATP).

In step (a) the net production of energy rich phosphate bonds will be about eight and in step (b) the net production of energy rich phosphate bonds will be about thirty, a total of thirty-eight.

In glycolysis in the absence of oxygen, the Electron Transport System ETS (which includes enzymes in which the co-enzyme part consists of molecules capable of providing an enol keto (quinol    quinone) structures, like tocopherols, ubiquinones, nicotinamide, ascorbic acid, and different dehydrogenases, as pointed out by Tamari and Rona1 ) will provide conditions in which dehydro-nicotinamide- adenine dinucleotide (NADH), the reduced form is reoxidized to NAD and the same cycle repeats itself again.

If for any reason the ETS stops fulfilling its role as in deficiency of a vitamin and/or mineral or the presence of toxic substances, then in order to maintain homeostasis in equilibrium, NADH will be oxidized by pyruvate in a reaction in which pyruvate will be reduced to lactate.

Lactate as the end product of glycolysis will provide approximately 20 percent of the expected total energy (8 phosphate bonds). Consequently, more glucose must undergo glycolysis to provide a given amount of energy under “anaerobic” as compared with “aerobic” conditions (Pasteur effect). Tissues that function under hypoxic circumstances tend to produce lactate3.

So, lactate will be the end product of the glycolysis process if the ETS is inhibited from performing its function, either due to a deficiency state in different co-enzymes or trace elements, or because of the presence of toxic substances which are substituting or inhibiting the essential co-enzymes and/or trace elements.

The end result will express itself - as is pointed out by Goldblatt and Cameron2 - in “oxygen” deficiency. The heart fibroblast tissue culture exposed to intermittent oxygen deficiency for long periods, led to the production of transplantable cancer cells. In agreement with this experiment, when glycolysis cannot follow its normal course and continue into the Krebs cycle, the homeostatic process of survival switches the energy production to a more primitive level, where it is maintained by fermentation (lower energy and lactate production). According to Warburg, this metabolic change will occur if the exposure to a deficiency state or toxic environment continues for a long period of time13.

This photograph shows the LDH isozymes in each of three preparations after electrophoretic resolution in starch gel. On the right is LDR-1, on the left LDH-5, and in the middle are the isozymes resulting from a mixture of equal quantities of these two preparations. All five isozymes were generated in the mix-ture in the approximate ration of 1:4:6:4:1, the expected distribution after random reassociation of subunits. The total enzyme activity in the mixture was the sum of the activities of the single isozyme preparations. All three preparations were placed in 1M NaCI and frozen overnight before electrophoretic resolution.

At this point there is an important question to be asked: in cases where this described process can be detected, at what stage is it still reversible? In the following, there is an attempt made to indicate this kind of possibility.

Over the years, enzymologists realized that the pure crystalline form of an enzyme may be substrate-specific, despite the difference in molecular forms4. The most researched enzyme turned out to be lactate dehydrogenase (LDH). Under specific conditions it proved to be separated by electrophoresis into five isozymes, each of them having a particular migration pattern5 characteristic of the organ of origin. In adult human heart and kidney the major isozymes are LDH-1, LDH-2, and LDH-3; whereas in adult human muscle and liver the dominant isozyme is LDH-5. Another type of pattern is exhibited by the spleen, LDH-3 being the predominant isozyme.

Apella et al.6 studied the structure of the LDH isozymes and were able to separate them into four polypeptide chains of equal size, which could be separated into two electrophoretically distinct forms; A and B polypeptides derived from LDH-1 (A 0 B4 ) and LDH-5 (A4 B0 ) were electrophoretically homogenous but containing different polypep-tides. Markert7 using a very simple and elegant technique, was able to prove that by mixing equal amounts of LDH-l (polypeptide B) and LDH-5 (polypeptide A), all five isozymes appear on electrophoretic separation (Figure 1). The possible combination of four subunits (tetramers) of two polypeptides A and B are:

Why should an enzyme exist in five forms, each of which can catalyze the same chemical reaction? At present one can offer only a partial explanation which is based on a few but highly significant experimental findings. During the normal breakdown of glucose (glycolysis), the major fates of pyruvate are: (1) conversion to lactate “anaerobic” glycolysis, and (2) conver-sion to carbon dioxide and water- through the “Krebs cycle”. In the case of skeletal muscle,

Binette et al.12 confirmed that there is a shift of the LDH isozymes in experimental animals under hypoxia from LDH-l (aerobic) to LDH-5 (anaerobic). Moreover, the reversibility of this trend after removal of the animals to room air is reported. These findings seem not only to confirm the claims made by Warburg that tissues.under hypoxic conditions (oxidation inhibited by the presence of poisons or by deficiency of certain vitamins and/or trace elements) switch from normal oxidative phosphorylation via the Krebs cycle to anaerobic glycolysis resulting in lactate formation, but also hold out the possibility that the change is reversible. A critical question may be asked at this point. If this trend can be detected, after how much time is this process reversible after being induced by different factors?

Time seems to be of considerable importance due to the fact that when cancer cells are already formed “cancer cells cannot regain normal respiration even in the course of many decades”13. If there was a method of following the metabolic process in which systemic lactic acid production could be monitored, the process might yet be stopped and reversed at the precancerous stage.

There is a working hypothesis suggesting that hypoxic conditions will result in lowering the intracellular pH level to a degree which is not compatible with normal cellular function. This supposition is supported by studies15-17 indicating the presence of an elevated serum lactate in different malignancies and other degenerative diseases (Table I). At the same time a very severe pH drop occurs in lactic aci-dosis25.

In the case of lactic acidosis, the homeostatic mechanism might take over, attempting to neutralize the accumulated acid (lactic) via salt formation. If such a working hypothesis were correct, an intracellular increase of alkali minerals, for example calcium and magnesium, could be expected. If tissue deposition of calcium and/or magnesium may occur via the vascular system, as in the above hypothesis, then elevated blood calcium may confirm this process. Data from Table II do indeed indicate an increased serum calcium in many degenerative diseases like malignant neoplasm of different organs and others, many of them without evidence of direct bone involvement18-24. Monitoring of the tissue deposition of alkali minerals (for screening purposes) would require the usage of a tissue which can serve as a reliable indicator of intracellular ion levels and which is stable and easily accessible.

As blood and urine do not fulfill these conditions the best choice we have is hair tissue14. Hair tissue seems to be a very sensitive indicator of minute changes in tissue levels of alkali (and other) minerals. The “early detection” of this kind of tissue mineral build up might serve as an indicator enabling necessary changes to be made in order to reverse this process.

The above hypothesis raises many questions as to the ways and means by which a nutritionally, environmentally, and socially induced degenerative process might be (a) detected, (b) halted, and (c) reversed. It would be promising indeed, were the scientific / medical community to take up the challenge of investigating these unanswered questions, and by doing so make a great contribution in the prevention of the appearance of many degenerative diseases.


I am indebted to Drs. J.H. Barker, H.W. Middleton, and D. Gaudin for reviewing and Mrs. L. Marsh for typing this manuscript.

  1. Tamari GM, Rona Z. Hair mineral levels and their correlation with abnormal glucose tolerance. Cytobiological Rev 1985; 4:191- 196.
  2. Goldblatt H, Cameron G. Induced malig-nancy in cells from rat myocardium sub-jected to intermittent anaerobiosis during long propagation in vitro. I Exp Med 1953; 97:525-552.
  3. Harper HA et al. Review of physiological chemistry. Lange Me4 Publications, Los Altos, CA 94022, 1953:298.
  4. Markert CL, Moeller F. Multiple forms of enzymes, tissue, ontogentic, and species specific patterns. Proc Nat Acd Sci 195945:753-763.
  5. Markert. CL, Ursprung H. The ontogeny of isozyme patterns of lactate dehydrogenase in the mouse. Develop Biol 1962:5:363- 381.
  6. Apelia Et, Markert CL. Dissociation of lac-tate dehydrogenase into subunits with guanidine hydrochloride. Biochem Biophys Res Comm 1961;6: 171-176.
  7. Markert CL. Lactate dehydrogenase isozymes: dissociation and recombination of subunits. Science 1963; 140:1329-1330.
  8. Plageman PGW, Gregory KE, Wroblewski F. The electrophoretically distinct forms of mammalian lactic dehydrogenase. 11 Properties and interrelationships of rabbit and human lactic dehydrogenase isozymes. I Biol Chem 1960;235: 2282-2287..
  9. Chan RD, Kaplan NO, Levine L, Zwilling E. Nature and development of lactic dehy-drogenases, Science 1962; 136: 962-969.
  10. Wilson AC, Chan RD, Kaplan NO. Functions of the two forms of lactic dehy-drogenase in the breast muscle of birds. Nature 1963; 197:331-334
  11. Rabinowitz Y, Dietz AA. Lactic dehydroge-nase of cultured lymphocytes: Response to different mitogenic stimuli and to varied oxygen tensions. Proc 3rd Annual Leucocyte Culture Conference 1967; 561- 571.
  12. Binette P, Pragay D, Rekate AA. Reversibility of the lactate dehydrogenase isozyme shift induced by low oxygen ten-sion. Life Science 1977; 20:1809-1814.
  13. Warburg 0. On the origin of cancer cells. Science 1956; 123: 309-314.
  14. Tamari GM. A primer on hair mineral analysis. Cytobiological Rev 1986; 3:17E186.
  15. Nisselbaum IS, Bodansky 0. Immunochemical and kinetic properties of anionic and cationic glutamic-oxaloacetic transaminase separated from human heart and human liver. I Biol Chem 1964; 235:4232-4236.
  16. Searcy RL. Diagnostic biochemistry. McGraw-Hill 1969. 17. Cohea ME, White PD. Life situations, emotions, and neuro circulatory asthenia. Research Nerv and Ment Dis Proc 1950; 29:832-869.
  17. Keller T et al. Hypercalcemia secondary to a primary hepatoma. IAMA 196S; 193: 782-784.
  18. Davidson I. Clinical diagnosis by laborato-ry methods. Henry JR (Ed) 16th Edition Philadelphia Saunders 1979.
  19. Chopia D, Clerken EP. Hypercalcemia and malignant disease. Med Clin N Amer 1977; 59:229-239.
  20. Bergsagel D et al. The treatment of plasma cell mycloma. Adv Cancer Res 1967; 10:311-359.
  21. Kennedy AC et a'. Abnormalities of miner-al metabolism suggestive of parathyroid overactivity in rheumatoid arthritis. Curr Med Res Opin 1975; 3:345-358.
  22. Wallach. Interpretation of diagnostic tests. Second Edition 1974.
  23. Howard IT. Clinical disorders of calcium homeostasis medicine (BaIt) 1963; 43:2545.
  24. Widmaxin FK. Clinical interpretation of laboratory tests (8th Edition) F.A. Davis Company, Philadelphia 1979; 338.
* - George M. Tamari, Ph.D., President, Anamol Laboratories
< Prev